Science Explorer Interactive view Map
Topic · Pulmonary and Respiratory Medicine

Lung Cancer Treatments and Mutations

Lung Cancer Treatments and Mutations is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 61k research works in it since 1950. 16.3% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the advancements in lung cancer research, particularly in understanding EGFR and ALK mutations, targeted therapy, resistance mechanisms to tyrosine kinase inhibitors, clinical trials evaluating different treatment regimens, genomic profiling for personalized medicine, and the development of treatment guidelines based on molecular biomarkers. The research also explores the concept of oncogene addiction and its implications for targeted therapies.

  • EGFR Mutations
  • Targeted Therapy
  • ALK Inhibitors
  • Resistance Mechanisms
  • Clinical Trials
  • Genomic Profiling
  • Chemotherapy Regimens
  • Biomarker Analysis
  • Treatment Guidelines
  • Oncogene Addiction
Research works
61k
fractional, since 1950
In the world top 10%
10k
per year above
Top-10% rate
16.3%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+23%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Lung Cancer Treatments and Mutations research?

By volume, China and the United States publish the most (3.5k and 3.1k works in 2022–2025).

By volume, 2022–2025

  1. 1 China 3.5k works
  2. 2 United States 3.1k works
  3. 3 Japan 1k works
  4. 4 Italy 488 works
  5. 5 Germany 464 works
  6. 6 India 451 works
  7. 7 United Kingdom 433 works
  8. 8 France 420 works
  9. 9 South Korea 394 works
  10. 10 Spain 328 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 32.9%United States: 29.5%Japan: 9.5%Italy: 4.6%6 others listed: 23.5%33%largest
China3,491 · 32.9%United States3,125 · 29.5%Japan1,003 · 9.5%Italy488 · 4.6%6 others listed2,490 · 23.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Lung Cancer Treatments and Mutations research?

By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Lung Cancer Treatments and Mutations research, followed by The University of Texas MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center.

By volume, 2022–2025

  1. 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 129 works
  2. 2 The University of Texas MD Anderson Cancer CenterUnited States 119 works
  3. 3 Memorial Sloan Kettering Cancer CenterUnited States 97 works
  4. 4 Sichuan UniversityChina 62 works
  5. 5 Sun Yat-sen UniversityChina 61 works
  6. 6 Dana-Farber Cancer InstituteUnited States 49 works
  7. 7 Shandong First Medical UniversityChina 48 works
  8. 8 Shanghai Chest HospitalChina 48 works
  9. 9 Peking UniversityChina 46 works
  10. 10 Shanghai Jiao Tong UniversityChina 46 works

Who are the leading researchers in Lung Cancer Treatments and Mutations?

The most-cited researchers publishing on Lung Cancer Treatments and Mutations include Patrick M. Bossuyt, Y. Wu and Lawrence H. Schwartz.

  1. 1 Patrick M. Bossuyt Netherlands 14k citations
  2. 2 Y. Wu China 7k citations
  3. 3 Lawrence H. Schwartz United States 5.8k citations
  4. 4 Ahmedin Jemal United States 4.9k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Lung Cancer Treatments and Mutations research done?

The largest centres of Lung Cancer Treatments and Mutations research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Plainview and Kashiwa.

Largest cities, 2022–2025

  1. 1 Beijing China 462 works
  2. 2 Shanghai China 356 works
  3. 3 Guangzhou China 332 works
  4. 4 New York United States 268 works
  5. 5 Seoul South Korea 234 works
  6. 6 Tokyo Japan 228 works
  7. 7 Boston United States 158 works
  8. 8 Nanjing China 157 works
  9. 9 Chengdu China 157 works
  10. 10 Hangzhou China 156 works

Where it is the local speciality

  1. PlainviewUS · 41.7 works42×
  2. KashiwaJP · 42.7 works37×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Lung Cancer Treatments and Mutations than the world average.

See Lung Cancer Treatments and Mutations on the map

Where is the best place to study Lung Cancer Treatments and Mutations?

Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, St. Marianna University School of Medicine and Shandong First Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 20.58%fractional works in this node (log) →share in the world top 10% →Chinese Academy of Medical Sciences & Peking Union Medical College: 129, 14.8%St. Marianna University School of Medicine: 11, 23.0%Shandong First Medical University: 48, 11.9%Kindai University: 20, 22.1%Cornell University: 27, 34.8%Shanghai Medical College of Fudan University: 11, 23.9%Nanjing Medical University: 45, 18.8%Kyoto Prefectural University of Medicine: 11, 9.5%King Saud University: 11, 29.9%Ulsan College: 12, 17.1%St. Marianna Univers…Kindai UniversityChinese Academy of M…Shandong First Medic…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 68.314.8%10.5×129 +114.4%
2 St. Marianna University School of MedicineJapan 62.423.0%18.4×11 +219.8%
3 Shandong First Medical UniversityChina 55.111.9%14.8×48 +62.0%
4 Kindai UniversityJapan 54.422.1%9.7×20 +22.2%
5 Cornell UniversityUnited States 54.334.8%2.2×27 +88.6%
6 Shanghai Medical College of Fudan UniversityChina 54.123.9%11.2×11 +31.5%
7 Nanjing Medical UniversityChina 50.818.8%7.0×45 +24.2%
8 Kyoto Prefectural University of MedicineJapan 50.49.5%12.0×11 +375.0%
9 King Saud UniversitySaudi Arabia 50.429.9%0.9×11 +246.4%
10 Ulsan CollegeSouth Korea 50.317.1%10.1×12 +53.5%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Lung Cancer Treatments and Mutations research growing?

Output in 2018–2022 was 23% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Lung Cancer Treatments and Mutations.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.